1. Home
  2. IMAB vs RECT Comparison

IMAB vs RECT Comparison

Compare IMAB & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • RECT
  • Stock Information
  • Founded
  • IMAB 2014
  • RECT 1997
  • Country
  • IMAB United States
  • RECT Singapore
  • Employees
  • IMAB N/A
  • RECT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • RECT
  • Sector
  • IMAB Health Care
  • RECT
  • Exchange
  • IMAB Nasdaq
  • RECT Nasdaq
  • Market Cap
  • IMAB 73.9M
  • RECT 66.1M
  • IPO Year
  • IMAB 2020
  • RECT 2024
  • Fundamental
  • Price
  • IMAB $1.31
  • RECT $4.67
  • Analyst Decision
  • IMAB Strong Buy
  • RECT
  • Analyst Count
  • IMAB 2
  • RECT 0
  • Target Price
  • IMAB $5.50
  • RECT N/A
  • AVG Volume (30 Days)
  • IMAB 238.6K
  • RECT 9.6K
  • Earning Date
  • IMAB 05-15-2025
  • RECT 03-27-2025
  • Dividend Yield
  • IMAB N/A
  • RECT N/A
  • EPS Growth
  • IMAB N/A
  • RECT N/A
  • EPS
  • IMAB N/A
  • RECT 0.14
  • Revenue
  • IMAB N/A
  • RECT $33,502,767.00
  • Revenue This Year
  • IMAB N/A
  • RECT N/A
  • Revenue Next Year
  • IMAB N/A
  • RECT N/A
  • P/E Ratio
  • IMAB N/A
  • RECT $33.72
  • Revenue Growth
  • IMAB N/A
  • RECT 8.42
  • 52 Week Low
  • IMAB $0.60
  • RECT $2.70
  • 52 Week High
  • IMAB $2.00
  • RECT $7.68
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 76.59
  • RECT N/A
  • Support Level
  • IMAB $0.90
  • RECT N/A
  • Resistance Level
  • IMAB $1.47
  • RECT N/A
  • Average True Range (ATR)
  • IMAB 0.10
  • RECT 0.00
  • MACD
  • IMAB 0.04
  • RECT 0.00
  • Stochastic Oscillator
  • IMAB 74.07
  • RECT 0.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About RECT Rectitude Holdings Ltd Ordinary Shares

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks.

Share on Social Networks: